Results are the measure of regenerative medicine.
Verifiable. Scalable. Trusted.
Dafan Health is built at the intersection of extracellular vesicle biology and stem cell science. We believe that trust in medicine begins with honest data, and that the value of innovation lies in reproducible results. Every decision returns to the scientific fundamentals — quantifiable, verifiable, trusted.
Results Define Value
Clinical outcomes define the standard for regenerative medicine. We believe the value of regenerative medicine must be built on verifiable clinical results. Every cellular application should have traceable data and long-term observational records.
Science Becomes Capability
We build standardized cell manufacturing and quality systems, giving cellular applications a measurable and reproducible foundation. Clinical tracking and data monitoring allow medical decisions to be grounded in reliable data.
From Research to Clinical
We connect cell research, bioprocessing, and clinical medicine to build regenerative medicine capabilities that can be applied clinically. Taking regenerative medicine from research to monitorable clinical application.
Results Define Value
Clinical outcomes define the standard for regenerative medicine. We believe the value of regenerative medicine must be built on verifiable clinical results. Every cellular application should have traceable data and long-term observational records.
Science Becomes Capability
We build standardized cell manufacturing and quality systems, giving cellular applications a measurable and reproducible foundation. Clinical tracking and data monitoring allow medical decisions to be grounded in reliable data.
From Research to Clinical
We connect cell research, bioprocessing, and clinical medicine to build regenerative medicine capabilities that can be applied clinically. Taking regenerative medicine from research to monitorable clinical application.
Applied autologous stem cells to periodontal disease treatment.
Applied autologous stem cell transplantation technology to burn treatment.
Industry-academia collaboration with USC professor; paper published in Oral Diseases international journal, receiving the 2010 Best Original Paper Award.
Dafan Health Co., Ltd. officially established. Development goals for 2025–2026 set as obtaining GTP certification and forming partnerships with major regional hospitals.
Years of Clinical Research
Healthcare Partners
Evidence-Based. Peer-Reviewed.
Academic Contribution · 01
This study evaluated the efficacy of MSC-derived extracellular vesicles (MSC-EVs) in chronic wound healing. Among 28 subjects receiving standardized EV preparations, wound area reduced by an average of 73% at week 12, with no significant immune rejection observed.
Academic Contribution · 02
Establishing cross-batch consistency in quality control systems is a core challenge for cell therapy commercialization. This study presents a standardized testing protocol covering cell viability, surface markers, and differentiation potential, completing 16 batch validations within 6 months with inter-batch coefficient of variation below 5%.
Academic Contribution · 03
Autologous chondrocyte implantation (ACI) was performed on 34 patients with knee cartilage defects. The average KOOS score improved by 38.4 points at 24 months post-surgery. MRI imaging showed complete cartilage fill in 91% of defect areas, with statistically significant clinical results (p < 0.001).
Academic Contribution · 04
By linking targeting peptides to exosome membranes via surface modification, therapeutic RNA cargo uptake in target tissues increased 4.3-fold. Both in vitro and small animal models showed significantly prolonged retention of engineered exosomes in joint cavities, providing new tools for precision regenerative medicine.
Years of Clinical Research
Healthcare Partners
Evidence-Based. Peer-Reviewed.
Academic Contribution · 01
This study evaluated the efficacy of MSC-derived extracellular vesicles (MSC-EVs) in chronic wound healing. Among 28 subjects receiving standardized EV preparations, wound area reduced by an average of 73% at week 12, with no significant immune rejection observed.
Academic Contribution · 02
Establishing cross-batch consistency in quality control systems is a core challenge for cell therapy commercialization. This study presents a standardized testing protocol covering cell viability, surface markers, and differentiation potential, completing 16 batch validations within 6 months with inter-batch coefficient of variation below 5%.
Academic Contribution · 03
Autologous chondrocyte implantation (ACI) was performed on 34 patients with knee cartilage defects. The average KOOS score improved by 38.4 points at 24 months post-surgery. MRI imaging showed complete cartilage fill in 91% of defect areas, with statistically significant clinical results (p < 0.001).
Academic Contribution · 04
By linking targeting peptides to exosome membranes via surface modification, therapeutic RNA cargo uptake in target tissues increased 4.3-fold. Both in vitro and small animal models showed significantly prolonged retention of engineered exosomes in joint cavities, providing new tools for precision regenerative medicine.
Academics & Clinicians, Together.
Founder & CEO
Dafan Health is focused on the translational application of regenerative medicine in chronic diseases and degenerative conditions, grounding extracellular vesicle and stem cell science in trusted clinical solutions, committed to closing the gap between fundamental research and patient benefit.
These are the numbers Dafan Health is working to change.
Obesity
Type 2 Diabetes
Alzheimer's Disease
Chronic Kidney Disease
Macular Degeneration
Metabolic Syndrome
